Profile data is unavailable for this security.
About the company
IDT Australia Limited is a pharmaceutical manufacturing company. The Company is engaged in the supply of products and provision of research and development and other technical services within the pharmaceutical and allied industries. Its business includes research and development, active pharmaceutical ingredient (API) and finished dosage form manufacture (FDF), clinical and commercial, project management, chemical services, analytical chemistry, pharmacy services, pharmaceutical development in all dosage forms, clinical packaging and regulatory affairs services. Its Current Good Manufacturing Practice (cGMP) manufacturing facilities produces both API and FDF across the medicinal cannabis manufacturing space. It also provides a full-scale service for new drug development and scale-up, commercial active drug manufacture as well as a variety of oral and injectable finished drug dose forms. Its analytical laboratories offer medicinal cannabis cGMP testing.
- Revenue in AUD (TTM)14.12m
- Net income in AUD-5.41m
- Incorporated1986
- Employees156.00
- LocationIDT Australia Ltd45 Wadhurst Dr, BoroniaMELBOURNE 3155AustraliaAUS
- Phone+61 (39) 801-8888
- Fax+61 (39) 801-8773
- Websitehttps://en.idtaus.com.au/
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Island Pharmaceuticals Ltd | 4.72k | -2.86m | 25.73m | -- | -- | 13.77 | -- | 5,450.27 | -0.0318 | -0.0318 | 0.00005 | 0.012 | 0.002 | -- | 0.0104 | -- | -124.17 | -- | -173.37 | -- | -- | -- | -60,684.75 | -- | -- | -544.58 | 0.2174 | -- | -57.45 | -- | -1.20 | -- | -- | -- |
| Bioxyne Ltd | 9.33m | -12.80m | 26.64m | 16.00 | -- | 7.38 | -- | 2.86 | -0.0066 | -0.0069 | 0.0049 | 0.0018 | 0.7646 | 3.78 | 10.33 | -- | -106.39 | -55.86 | -134.91 | -72.24 | 36.44 | 37.54 | -139.14 | -85.30 | 1.18 | -- | 0.0526 | -- | 80.91 | 34.32 | -576.55 | -- | 50.56 | -- |
| Noxopharm Ltd | 2.41m | -3.58m | 29.22m | 1.00k | -- | 5.32 | -- | 12.14 | -0.0123 | -0.0123 | 0.0082 | 0.0188 | 0.2847 | -- | 0.5672 | -- | -42.31 | -43.24 | -48.67 | -52.58 | -- | -- | -148.64 | -170.07 | -- | -- | 0.00 | -- | -60.33 | -9.37 | 76.24 | -- | -- | -- |
| Prescient Therapeutics Ltd | 687.57k | -8.24m | 30.60m | 3.00 | -- | 1.69 | -- | 44.51 | -0.0102 | -0.0102 | 0.0009 | 0.0224 | 0.0284 | -- | 3.31 | -- | -33.97 | -28.85 | -37.31 | -30.66 | -- | -- | -1,198.14 | -2,096.39 | -- | -288.97 | 0.018 | -- | 49.77 | 56.99 | -17.61 | -- | -- | -- |
| Amplia Therapeutics Ltd | 4.44m | -4.50m | 32.24m | 1.00 | -- | 1.61 | -- | 7.27 | -0.0221 | -0.0221 | 0.0218 | 0.0561 | 0.2647 | -- | 2.05 | -- | -26.86 | -25.13 | -32.90 | -27.42 | -- | -- | -101.48 | -206.74 | -- | -- | 0.122 | -- | 286.42 | 144.81 | 27.86 | -- | -6.91 | -- |
| Rhythm Biosciences Ltd | 52.28k | -6.86m | 34.80m | -- | -- | 40.13 | -- | 665.71 | -0.0301 | -0.0301 | 0.0002 | 0.0035 | 0.0114 | 1.91 | 1.02 | -- | -148.83 | -134.13 | -199.13 | -168.97 | -4,946.29 | -1,807.84 | -13,115.47 | -9,433.23 | 1.58 | -1,750.40 | 0.1589 | -- | -77.10 | -18.01 | 16.56 | -- | -5.69 | -- |
| LBT Innovations Limited | 1.31m | -3.74m | 35.15m | 17.00 | -- | 18.86 | -- | 26.83 | -0.0032 | -0.0032 | 0.001 | 0.0011 | 0.1712 | 0.0959 | 2.52 | -- | -48.89 | -34.86 | -78.03 | -38.53 | 88.63 | -- | -285.50 | -513.87 | 2.56 | -12.08 | 0.5686 | -- | -39.04 | -14.71 | 83.40 | -- | -69.50 | -- |
| Cynata Therapeutics Ltd | 417.71k | -9.74m | 38.85m | 0.00 | -- | 5.35 | -- | 93.00 | -0.0543 | -0.0543 | 0.0023 | 0.0402 | 0.0305 | -- | 1.85 | -- | -71.18 | -39.49 | -81.37 | -42.96 | -- | -- | -2,332.89 | -515.32 | -- | -- | 0.00 | -- | 18.38 | 16.51 | 31.75 | -- | -- | -- |
| IDT Australia Limited | 14.12m | -5.41m | 42.98m | 156.00 | -- | 1.50 | -- | 3.04 | -0.0154 | -0.0154 | 0.0404 | 0.0667 | 0.4734 | 1.84 | 2.62 | -- | -18.15 | -9.77 | -22.59 | -11.61 | 80.11 | 84.61 | -38.33 | -23.12 | 1.12 | -50.05 | 0.1601 | -- | 100.81 | 3.09 | 36.30 | -- | -10.39 | -- |
| Tryptamine Therapeutics Ltd | -100.00bn | -100.00bn | 55.19m | -- | -- | 9.12 | -- | -- | -- | -- | -- | 0.0049 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | 0.0342 | -- | -- | -- | -- | -- | -- | -- |
| Anteotech Ltd | 514.89k | -8.88m | 58.27m | 40.00 | -- | 9.38 | -- | 113.18 | -0.0039 | -0.0039 | 0.0002 | 0.0021 | 0.0699 | -- | 2.55 | -- | -120.47 | -75.24 | -159.35 | -84.74 | -- | -- | -1,724.74 | -1,444.66 | -- | -- | 0.3055 | -- | 26.85 | 27.93 | 29.82 | -- | 68.39 | -- |
| Holder | Shares | % Held |
|---|---|---|
| Sandon Capital Pty Ltd.as of 10 Jul 2024 | 77.33m | 17.99% |
| Regal Funds Management Pty Ltd.as of 13 Jun 2023 | 44.74m | 10.41% |
| Schr�der Equities GmbHas of 31 Oct 2024 | 1.05m | 0.25% |
